x

Search for a diagnostic test

* (*) mandatory field

106 Result(s)

Filter by

Speciality(ies)/objective(s)

Technique(s)

Purpose(s)

Quality management

Country(ies)

Reset
Sort by

Caption : Accreditation =Accreditation ;

FRANCE

AUVERGNE-RHONE-ALPES
BRON

Accreditation Neonatal screening of congenital adrenal hyperplasia
CHU de Lyon HCL - GH Est
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
FRANCE

AUVERGNE-RHONE-ALPES
GRENOBLE

Accreditation Neonatal screening of congenital adrenal hyperplasia
CHU de Grenoble et des Alpes - Institut de biologie et de pathologie
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
FRANCE

PAYS DE LA LOIRE
ANGERS

Accreditation Neonatal screening of congenital adrenal hyperplasia
CHU d'Angers
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
FRANCE

ILE-DE-FRANCE
SAINT-OUEN-L'AUMÔNE

Accreditation Diagnosis of congenital adrenal hyperplasia (21-hydroxylase, 11-hydroxylase, 3-beta-hydroxysteroid dehydrogenase)
Laboratoire Cerba
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
GERMANY

Hamburg
HAMBURG

Accreditation Diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, HSD3B2 genes)
Labor Lademannbogen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Niedersachsen
HANNOVER

Accreditation Diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP21A2, HSD3B2 genes)
amedes genetics im MVZ wagnerstibbe
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, HSD3B2, POR genes)
Zweigniederlassung der SYNLAB MVZ Augsburg GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Bayern
REGENSBURG

Accreditation Diagnosis of congenital adrenal hyperplasia (CYP21A2 gene: sequencing / MLPA; CYP11B1, HSD3B2, POR genes: sequencing)
Universitätsklinikum Regensburg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
AUSTRIA

TIROL
INNSBRUCK

Accreditation Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, CYP11B1, and HSD3B2 genes)
Medizinische Universität Innsbruck
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Rheinland-Pfalz
INGELHEIM AM RHEIN

Accreditation Diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, HSD3B2 genes)
Bioscientia Institut für Medizinische Diagnostik GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation Diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, HSD3B2 genes)
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
UNITED KINGDOM

Greater Manchester
MANCHESTER

Accreditation Molecular diagnosis of Congenital Adrenal Hyperplasia (CYP21A2 gene: Diagnosis available by (pre-natal diagnostic / post-natal targetted mutation analysis)
St Mary's Hospital
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : Sanger sequencing, PCR based techniques

More information
SWITZERLAND

Suisse Romande
GENÈVE

Accreditation Search of duplications and/or deletions by array-CGH
Hôpitaux Universitaires de Genève HUG
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics, Cytogenetics
Objective(s) : Deletion / Duplication analysis, Detection of chromosome alterations large in size
Technique(s) : Array based techniques, FISH

More information
UNITED KINGDOM

West Yorkshire
LEEDS

Accreditation Molecular diagnosis of Congenital Adrenal Hyperplasia (MLPA for dosage/genomic rearrangements plus analysis of common point mutations, CYP21A2 gene)
St James's University Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : MLPA based techniques

More information
GERMANY

Sachsen
DRESDEN

Accreditation Diagnosis of congenital adrenal hyperplasia (CYP17A1, CYP21A2, CYP11B1, HSD3B2, STAR genes)
MVZ Mitteldeutscher Praxisverbund Humangenetik GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Baden-Württemberg
MANNHEIM

Accreditation Diagnosis of congenital adrenal hyperplasia (CYP21A2, HSD3B2 genes)
Zentrum für Humangenetik Mannheim
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
NETHERLANDS

Gelderland
NIJMEGEN

Accreditation Molecular diagnosis of Congenital Adrenal Hyperplasia due to 3-beta-Hydroxysteroid Dehydrogenase Deficiency (HSD3B2 gene)
Radboudumc - Radboud universitair medisch centrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

Accreditation Molecular diagnosis of Congenital Adrenal Hyperplasia (DAX1 analysis)
Newcastle upon Tyne Hospitals NHS Trust
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
FRANCE

HAUTS-DE-FRANCE
LILLE

Accreditation Neonatal screening of congenital adrenal hyperplasia
CHU de Lille - Centre de Biologie Pathologie Génétique
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
GERMANY

Baden-Württemberg
FREIBURG

Accreditation Diagnosis of congenital adrenal hyperplasia (CY11B1, CYP21A2, HSD3B2 genes)
Synlab MVZ Freiburg GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
UNITED KINGDOM

Greater London
LONDON

Accreditation Diagnosis of Congenital adrenal hyperplasia (Analytes: 17 hydroxyprogesterone, renin, aldosterone, DHEAS & urine steroid profiles)
Biochemistry services - UCL Hospitals Foundation NHS Trust
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SWEDEN

Region Stockholm
STOCKHOLM

Accreditation Diagnosis of congenital adrenal hyperplasia 11-beta-hydroxylase, 17-alpha-hydroxylase, 17-beta-hydroxylase, 21-beta-hydroxylase (HSD3B2, CYP11B1, CYP17A1, HSD17B3, CYP21A2 genes)
Karolinska Universitetssjukhuset - Solna
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Accreditation Diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP21A2 and HSD3B2 genes)
Diagenom GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
FRANCE

AUVERGNE-RHONE-ALPES
BRON

Accreditation Diagnosis of congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency (HSD3B2 gene)
CHU de Lyon HCL - GH Est
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
UNITED KINGDOM

Greater London
LONDON

Accreditation Diagnosis of Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency (HSD3B2: whole gene sequencing)
Biochemistry services - UCL Hospitals Foundation NHS Trust
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Hamburg
HAMBURG

Accreditation Diagnosis of congenital adrenal hyperplasia (CY11B1, CYP21A2, HSD3B2 genes)
MVZ Fenner & Krasemann
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
UNITED KINGDOM

Merseyside
LIVERPOOL

Accreditation Molecular diagnosis of Sex Determination For X-Linked Conditions For Disorders That Manifest Significantly Different In One Sex Compared To The Other by Targetted Mutation and Copy Number Analysis (Genes: AMELX, AMELY, SRY)
Liverpool Women's NHS Foundation Trust
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

Accreditation Molecular diagnosis of Congenital Adrenal Hyperplasia (NR0B1 gene: Sequencing of the entire coding region of gene (s) / Testing for known mutations in family members)
Newcastle upon Tyne Hospitals NHS Trust
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
FRANCE

AUVERGNE-RHONE-ALPES
BRON

Accreditation Diagnosis of primary adrenal insufficiency (Panel)
CHU de Lyon HCL - GH Est
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

ILE-DE-FRANCE
LE KREMLIN-BICÊTRE

Accreditation Diagnosis of sex development disorders and peripheral infertilities (Panel)
CHU Paris-Sud - Hôpital de Bicêtre
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques, MLPA based techniques

More information
SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation Diagnosis of congenital adrenal hyperplasia (gene panel)
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
NETHERLANDS

Utrecht
UTRECHT

Accreditation Molecular diagnosis of Nonsyndromal Disorders of Sex Development (gene panel; DSD00v16.1)
UMC Utrecht - Universitair Medisch Centrum Utrecht
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

ILE-DE-FRANCE
LE KREMLIN-BICÊTRE

Accreditation Diagnosis of sex development disorders (Panel)
CHU Paris-Sud - Hôpital de Bicêtre
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
FRANCE

ILE-DE-FRANCE
LE KREMLIN-BICÊTRE

Accreditation Diagnosis of peripheral infertility (Panel)
CHU Paris-Sud - Hôpital de Bicêtre
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation Diagnosis of disorder of sex development (panel)
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

NOUVELLE AQUITAINE
POITIERS

Accreditation Diagnosis of developmental abnormalities (Whole exome)
CHU de Poitiers
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Whole Exome Sequencing (WES)

More information
FRANCE

NORMANDIE
ROUEN

Accreditation Diagnosis of developmental abnormalities and intellectual disability (Whole exome)
CHU de Rouen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Whole Exome Sequencing (WES)

More information
BELGIUM

OOST-VLAANDEREN
GENT

Accreditation Diagnosis of sex development disorders (gene panel)
Center for Medical Genetics Gent
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Whole Exome Sequencing (WES)

More information
ITALY

TRENTINO ALTO ADIGE
ROVERETO

Accreditation Diagnosis of hypospadias [panel of genes]
MAGI'S LAB srl
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
FRANCE

BOURGOGNE-FRANCHE-COMTE
DIJON

Accreditation Neonatal screening of congenital adrenal hyperplasia
CHU de Dijon - Plateau technique de Biologie
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
GERMANY

Schleswig-Holstein
KIEL

Accreditation Diagnosis of congenital adrenal hyperplasia (CYP11A1, CYP11B1, CYP17A1, CYP21A2, HSD3B2, POR, STAR genes)
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
GERMANY

Baden-Württemberg
HEIDELBERG

Accreditation Diagnosis of 3-beta-hydroxysteroid dehydrogenase deficiency (HSD3B2 gene)
Zentrallabor des Universitätsklinikums Heidelberg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Sachsen
DRESDEN

Accreditation Neonatal screening : Diagnosis of congenital adrenal hyperplasia
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
BELGIUM

ANTWERPEN
ANTWERPEN

Accreditation Neonatal screening: Biochemical diagnosis of Congenital Adrenal Hyperplasia (17-OH-progesterone: GSP (Delfia method), bloodspots)
Provinciaal Centrum voor opsporing van Metabole Aandoeningen (PCMA) - Antwerpen
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
BELGIUM

LIEGE
LIEGE

Accreditation Neonatal screening: Biochemical diagnosis of Congenital Adrenal Hyperplasia (17-OH-progesterone: ELISA, bloodspots)
CHU Sart Tilman - Liège
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

Accreditation Neonatal screening of congenital adrenal hyperplasia
CHRU de Besançon - Hôpital Saint-Jacques
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
GERMANY

Niedersachsen
RONNENBERG

Accreditation Newborn screening : Diagnosis of congenital adrenal hyperplasia (Immunoassay, tandem mass spectrometry, steroid profile by LC-MSMS)
Screening-Labor Hannover
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis, Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay, Protein expression
Technique(s) : Immunohistochemistry

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of disorder sex development (Panel)
CHU Paris - Hôpital Robert Debré
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
ITALY

LAZIO
ROMA

Molecular diagnosis of congenital adrenal hyperplasia (CYP21A1 gene)
Laboratorio Genoma
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

SARDEGNA
CAGLIARI

Molecular diagnosis of congenital adrenal hyperplasia (CYP21 gene)
Ospedale Regionale per le Microcitemie
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Nordrhein-Westfalen
DÜSSELDORF

Diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, CYP17A1, HSD3B2 genes)
Zotz|Klimas Standort Düsseldorf
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

Galicia
SANTIAGO DE COMPOSTELA

Diagnosis of congenital adrenal hyperplasia (CYP21A2, CYP11B1, CYP17A1, HSD3B2 genes)
Hospital Clínico Universitario de Santiago
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

More information
ITALY

LOMBARDIA
MILANO

Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
IRCCS Ospedale San Raffaele
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

PIEMONTE
TORINO

Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
A.O.U. Città della Salute e della Scienza di Torino - Ospedale Molinette
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Niedersachsen
OSNABRÜCK

Diagnosis of congenital adrenal hyperplasia (CYP17A1, CYP21A2, CYP11B1, HSD3B2 genes)
Praxis Dres. Gencik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Baden-Württemberg
STUTTGART

Diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, HSD3B2 genes)
Klinikum Stuttgart - Standort Olgahospital
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
SPAIN

Cataluña
BARCELONA

Diagnosis of congenital adrenal hyperplasia (CYP21A2, CYP11B1, HSD3B2 genes)
Hospital Clínic de Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
TURKEY

TURKEY
ISTANBUL

Molecular diagnosis of congenital adrenal hyperplasia
Acibadem healthcare group
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Diagnosis of congenital adrenal hyperplasia (CYP17A1, CYP21A2, HSD3B2 genes)
Centogene AG
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Hamburg
HAMBURG

Diagnosis of congenital adrenal hyperplasia (CY11B1, CYP17A1, CYP21A2, HSD3B2 genes: sequencing / MLPA)
Gemeinschaftspraxis für Humangenetik GbR
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
POLAND

Warszawa
WARSAW

Molecular diagnostics of congenital adrenal hyperplasia (CYP21A2 gene)
Instytut "Pomnik-Centrum Zdrowia Dziecka"
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
SPAIN

Andalucía
MÁLAGA

Diagnosis of congenital adrenal hyperplasia (HSD3B2 gene)
IMEGEN - Delegación Málaga
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
SPAIN

Madrid
SAN SEBASTIÁN DE LOS REYES

Diagnosis of congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency (HSD3B2 gene)
LabGenetics - Laboratorio de Genética Clínica, S.L.
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Sachsen
DRESDEN

Diagnosis of congenital adrenal hyperplasia (CYP21A2, HSD3B2 genes: sequencing / MLPA)
Gemeinschaftspraxis für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Berlin
BERLIN

Diagnosis of congenital adrenal hyperplasia (CYP11A1, CYP11B1, CYP17A1, CYP21A2, HSD3B2, POR, genes)
Labor Medicover Humangenetik Berlin Lichtenberg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

País Vasco
BARAKALDO

Diagnosis of disorders of sex development (panel)
Instituto de Investigación sanitaria Biocruces Bizkaia
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
HUNGARY

Közép-Magyarország
BUDAPEST

Mutation screening in Congenital Adrenal Hyperplasia
2nd Department of Internal Medicine, Semmelweis University
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

More information
ITALY

TOSCANA
PISA

Diagnosis of 46 XY disorder of sex development [panel of genes]
Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
SPAIN

Comunidad Valenciana
ELCHE

Diagnosis of congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency (HSD3B2 gene)
Bioarray
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Madrid
MADRID

Diagnosis of disorders of sex development (panel)
Hospital Universitario Fundación Jiménez Díaz
Purpose(s) : Antenatal diagnosis, Pre-implantation diagnosis, Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
ITALY

LOMBARDIA
PAVIA

Diagnosis of sexual development disorders [panel of genes]
Microgenomics S.r.l.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

País Vasco
SAN SEBASTIÁN

Diagnosis of congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency (HSD3B2 gene)
DNA Data
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of disorders of sex differentiation (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Madrid
TRES CANTOS

Diagnosis of congenital adrenal hyperplasia (CYP17A1, CYP21A2, CYP11B1, HSD3B2, POR, STAR genes)
Centro de estudios genéticos ATG Medical
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

NORMANDIE
CAEN

Neonatal screening of congenital adrenal hyperplasia
CHU de Caen - Hôpital de la Côte de Nacre
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
FRANCE

GRAND-EST
STRASBOURG

Neonatal screening of congenital adrenal hyperplasia
CHU de Strasbourg - Hôpital Civil
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
FRANCE

NOUVELLE AQUITAINE
PESSAC

Neonatal screening of congenital adrenal hyperplasia
CHU de Bordeaux-GH Sud - Hôpital Haut-Lévêque
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
FRANCE

HAUTS-DE-FRANCE
LILLE

Neonatal screening of congenital adrenal hyperplasia
Centre régional de dépistage néonatal
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
FRANCE

PAYS DE LA LOIRE
NANTES

Neonatal screening of congenital adrenal hyperplasia
CHU de Nantes - Hôpital mère-enfant
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
GERMANY

Hessen
GIEßEN

Diagnostics and monitoring of steroid related disorders by gas chromatography-mass spectrometry or liquid chromatography-tandem mass spectrometry (steroid metabolomics)
Kinderklinik des UKGM am Standort Gießen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
PORTUGAL

SUL
LISBOA

Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

CAMPANIA
NAPOLI

Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
Azienda Ospedaliera Universitaria "Federico II"
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

SICILIA
PALERMO

Molecular diagnosis of congenital adrenal hyperplasia (CYP21 gene)
Azienda Ospedaliera Ospedali Riuniti "Villa Sofia-Cervello" - Presidio Cervello
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
PORTUGAL

NORTE
PORTO

Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene): analysis of the entire coding region and UTR 5' and deletion/duplication analysis.
Faculdade de Medicina da Universidade do Porto
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis

More information
IRELAND

County Dublin
DUBLIN

Biochemical diagnosis of congenital adrenal hyperplasia
Mater Misericordiae Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
ROMANIA

CLUJ
CLUJ

Biochemical diagnosis of congenital adrenal hyperplasia
Spitalul de Pediatrie Copii Cluj
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
ROMANIA

CLUJ
CLUJ

Molecular and biochemical diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 11-betahydroxylase deficiency
U.M.F. Iuliu Hatieganu Cluj
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics, Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
CYPRUS

Cyprus
NICOSIA

Full mutation analysis via sequencing for Congenital Adrenal Hyperplasia (CYP21A2 gene 6p31.23)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

EMILIA ROMAGNA
BOLOGNA

Diagnosis of congenital adrenal hyperplasia (CYP21 gene)
Policlinico S. Orsola-Malpighi - Area S. Orsola
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics, Cytogenetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Methylation analysis, Detection of microdeletions/microduplications
Technique(s) : Sanger sequencing, MLPA based techniques

More information
CZECH REPUBLIC

South Moravia
BRNO

Postnatal and prenatal molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
University hospital Brno
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
HUNGARY

Közép-Magyarország
BUDAPEST

Molecular diagnosis of congenital adrenal hyperplasia by allele-specific amplification (CYP21A2 gene)
Semmelweis University Hospital - 2nd Department of Paediatrics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

LOMBARDIA
MILANO

Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
ASST Grande Ospedale Metropolitano Niguarda
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
ITALY

LOMBARDIA
MILANO

Biochemical diagnosis of congenital adrenal hyperplasia
Ospedale dei Bambini ''Vittore Buzzi"
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
GERMANY

Baden-Württemberg
HEIDELBERG

Newborn screening : Diagnosis of congenital adrenal hyperplasia
Dietmar-Hopp-Stoffwechselzentrum
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
GERMANY

Nordrhein-Westfalen
BONN

Diagnosis of congenital adrenal hyperplasia (CYP21A2, HSD3B2 genes)
MVZ Institut für Klinische Genetik und Tumorgenetik Bonn GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SLOVENIA

SLOVENIA
LJUBLJANA

Molecular diagnosis of congenital adrenal hyperplasia (CYP21 gene)
University Medical Centre Ljubljana
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ISRAEL

ISRAEL
JERUSALEM

Molecular diagnosis of Congenital Adrenal Hyperplasia (CYP21A2, Linkage analysis, PGD)
Shaare Zedek Medical Center
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
UNITED KINGDOM

Greater Manchester
MANCHESTER

Biochemical diagnosis of Congenital Adrenal Hyperplasia (Fluoroimmunoassay)
Central Manchester University Hospitals - Clinical Sciences Building (CSB3)
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
LEBANON

Beyrouth
BEIRUT

Molecular diagnosis of congenital adrenal hyperplasia (complete CYP21A2 gene sequencing)
Université Saint-Joseph
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
SLOVENIA

SLOVENIA
MARIBOR

Molecular diagnosis of congenital adrenal hyperplasia
Maribor general hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
AUSTRIA

WIEN
WIEN

Austrian newborn screening program for inherited metabolic and endocrine disorders
Allgemeines Krankenhaus der Stadt Wien
Purpose(s) : Newborn screening
Specialty(ies) : Biochemical genetics
Objective(s) : Analyte / Enzyme assay

More information
CROATIA

CROATIA
ZAGREB

Molecular diagnosis of Congenital Adrenal Hyperplasia
Children's University Hospital Zagreb
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Berlin
BERLIN

Diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, HSD3B2 genes)
IFLb Laboratoriumsmedizin Berlin GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
CYPRUS

Cyprus
NICOSIA

Full mutation analysis for Congenital Adrenal Hyperplasia via MLPA (CYP21A2 gene 6p31.23)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Technique(s) : MLPA based techniques

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutation for Congenital Adrenal Hyperplasia (CYP21A2 gene 6p31.23)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

DNA storage/extraction of CYP21A2 for Congenital Adrenal Hyperplasia (CYP21A2 gene 6p31.23)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information